Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Piccart

Showing results (71-80 of 186) with videos related to

Pageof 19
Sort By:
Ecancermedicalscience|December 20, 2014
Hurdles and delays in access to anti-cancer drugs in EuropeF Ades, D Zardavas, C Senterre, et al.
ESMO Open|January 15, 2021
Flexible care in breast cancerA Wardley, J-L Canon, L Elsten, et al.
Lancet (London, England)|December 3, 1994
Tumour stimulating effects of recombinant human interleukin-6C Ravoet, J DeGrève, K Vandewoude, et al.
ESMO Open|March 13, 2022
"The first ones now, will later be last": understanding the importance of historical context when reading ESMO-MCBS scoresN I Cherny, U Dafni, G Pentheroudakis, et al.
European Journal of Cancer (Oxford, England : 1990)|April 9, 2002
An EORTC-IDBBC phase I study of gemcitabine and continuous infusion 5-fluorouracil in patients with metastatic breast cancer resistant to anthracyclines or pre-treated with both anthracyclines and taxanesA Awada, L Biganzoli, T Cufer, et al.
Clinical Genetics|May 27, 2015
Frequent incidence of BARD1-truncating mutations in germline DNA from triple-negative breast cancer patientsS De Brakeleer, J De Grève, C Desmedt, et al.
Gynecologic Oncology|February 27, 2004
Rates of topoisomerase II-alpha and HER-2 gene amplification and expression in epithelial ovarian carcinomaM S Mano, A Awada, A Di Leo, et al.
European Journal of Cancer (Oxford, England : 1990)|April 29, 2000
Summary measures and statistics in the analysis of quality of life data: an example from an EORTC-NCIC-SAKK locally advanced breast cancer studyD Curran, N Aaronson, B Standaert, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1981
Phase I clinical trial with alpha 1,3,5- triglycidyl-s-triazinetrione (NSC-296934)M Piccart, M Rozencweig, P Dodion, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2014
Controversial issues in early-stage breast cancer: a global collaborative survey, supported by the European Society for Medical Oncology (ESMO)D Zardavas, F Ades, I B Spasojevic, et al.
Pageof 19

Showing results (71-80 of 186) with videos related to

Sort By:
Pageof 19
Ecancermedicalscience|December 20, 2014
Hurdles and delays in access to anti-cancer drugs in EuropeF Ades, D Zardavas, C Senterre, et al.
ESMO Open|January 15, 2021
Flexible care in breast cancerA Wardley, J-L Canon, L Elsten, et al.
Lancet (London, England)|December 3, 1994
Tumour stimulating effects of recombinant human interleukin-6C Ravoet, J DeGrève, K Vandewoude, et al.
ESMO Open|March 13, 2022
"The first ones now, will later be last": understanding the importance of historical context when reading ESMO-MCBS scoresN I Cherny, U Dafni, G Pentheroudakis, et al.
European Journal of Cancer (Oxford, England : 1990)|April 9, 2002
An EORTC-IDBBC phase I study of gemcitabine and continuous infusion 5-fluorouracil in patients with metastatic breast cancer resistant to anthracyclines or pre-treated with both anthracyclines and taxanesA Awada, L Biganzoli, T Cufer, et al.
Clinical Genetics|May 27, 2015
Frequent incidence of BARD1-truncating mutations in germline DNA from triple-negative breast cancer patientsS De Brakeleer, J De Grève, C Desmedt, et al.
Gynecologic Oncology|February 27, 2004
Rates of topoisomerase II-alpha and HER-2 gene amplification and expression in epithelial ovarian carcinomaM S Mano, A Awada, A Di Leo, et al.
European Journal of Cancer (Oxford, England : 1990)|April 29, 2000
Summary measures and statistics in the analysis of quality of life data: an example from an EORTC-NCIC-SAKK locally advanced breast cancer studyD Curran, N Aaronson, B Standaert, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1981
Phase I clinical trial with alpha 1,3,5- triglycidyl-s-triazinetrione (NSC-296934)M Piccart, M Rozencweig, P Dodion, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2014
Controversial issues in early-stage breast cancer: a global collaborative survey, supported by the European Society for Medical Oncology (ESMO)D Zardavas, F Ades, I B Spasojevic, et al.
Pageof 19